• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩与帕金森病相比脑脊液中神经丝轻链水平的Meta分析

Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.

作者信息

Hu Xiaohui, Yang Yan, Gong Daokai

机构信息

Department of Neurology, Jingzhou Central Hospital, Tongji Medical College, Huazhong University of Science Technology, Renming Road No. 1, Jingzhou City, 434020, Hubei Province, China.

Hubei College of Chinese Medicines, Jingzhou, China.

出版信息

Neurol Sci. 2017 Mar;38(3):407-414. doi: 10.1007/s10072-016-2783-7. Epub 2016 Nov 28.

DOI:10.1007/s10072-016-2783-7
PMID:27896490
Abstract

As a biomarker of axonal injury, neurofilament light chain (NFL) in multiple system atrophy (MSA) patients and Parkinson's disease (PD) patients has been investigated by numerous studies. However, cerebrospinal fluid (CSF) NFL changes are conflicting in MSA patients relative to PD patients to date. Therefore, the current study was carried out to find out possible heterogeneity sources. Furthermore, "Neurofilament", "Neurofilament light chain" and "Multiple system atrophy" were employed to search "PubMed", "Springer" and "Medline" databases until August 2016 with standard mean difference (Std.MD) being calculated. In addition, subgroup analysis and meta-regression were performed to assess possible heterogeneity sources. Nine studies were pooled, in which 212 MSA patients and 373 PD patients were involved. Moreover, CSF NFL in MSA patients was higher than that in PD patients [pooled Std.MD = 1.56, 95% CI (1.12, 2.00), p < 0.00001] with significant heterogeneity (I  = 76%). Besides, population variations, sample size, the difference in CSF phosphorylated tau (p-tau) levels between MSA patients and PD patients, and Hoehn-Yahr staging of PD patients were the main heterogeneity sources. As shown by meta-regression, Hedges's g of CSF NFL was correlated with CSF Std.MD of α-synuclein between MSA patients and healthy controls (r = -1.34824, p = 0.00025). Therefore, CSF NFL increased in MSA patients relative to PD patients. Meta-regression showed that NFL was associated with α-synuclein in CSF of MSA patients relative to healthy controls. Due to the influence of heterogeneity sources, more prospective large sample studies are still needed to assess CSF NFL changes in MSA patients relative to PD patients.

摘要

作为轴突损伤的生物标志物,神经丝轻链(NFL)在多系统萎缩(MSA)患者和帕金森病(PD)患者中已得到大量研究。然而,迄今为止,MSA患者脑脊液(CSF)中NFL的变化与PD患者相比存在矛盾。因此,开展本研究以找出可能的异质性来源。此外,使用“神经丝”“神经丝轻链”和“多系统萎缩”检索“PubMed”“Springer”和“Medline”数据库至2016年8月,并计算标准平均差(Std.MD)。另外,进行亚组分析和元回归以评估可能的异质性来源。汇总了9项研究,涉及212例MSA患者和373例PD患者。而且,MSA患者脑脊液中的NFL高于PD患者[合并Std.MD = 1.56,95%CI(1.12,2.00),p < 0.00001],存在显著异质性(I = 76%)。此外,人群差异、样本量、MSA患者和PD患者脑脊液磷酸化tau(p-tau)水平的差异以及PD患者的Hoehn-Yahr分期是主要的异质性来源。元回归显示,MSA患者与健康对照之间脑脊液NFL的Hedges's g与α-突触核蛋白的脑脊液Std.MD相关(r = -1.34824,p = 0.00025)。因此,与PD患者相比,MSA患者脑脊液NFL升高。元回归显示,相对于健康对照,MSA患者脑脊液中的NFL与α-突触核蛋白相关。由于异质性来源的影响,仍需要更多前瞻性大样本研究来评估MSA患者与PD患者相比脑脊液NFL的变化。

相似文献

1
Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.多系统萎缩与帕金森病相比脑脊液中神经丝轻链水平的Meta分析
Neurol Sci. 2017 Mar;38(3):407-414. doi: 10.1007/s10072-016-2783-7. Epub 2016 Nov 28.
2
Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.脑脊液中神经丝轻链水平可区分帕金森病与非典型帕金森综合征:一项荟萃分析的证据
J Neurol Sci. 2015 May 15;352(1-2):84-7. doi: 10.1016/j.jns.2015.03.041. Epub 2015 Apr 7.
3
Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.脑脊液神经丝轻链蛋白在帕金森病性障碍鉴别诊断中的应用:一项荟萃分析
Neurosci Lett. 2018 Oct 15;685:35-41. doi: 10.1016/j.neulet.2018.07.030. Epub 2018 Jul 20.
4
CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease.脑脊液神经丝轻链和tau蛋白可区分多系统萎缩与帕金森病。
Neurobiol Aging. 2007 May;28(5):742-7. doi: 10.1016/j.neurobiolaging.2006.03.010. Epub 2006 May 6.
5
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.与帕金森病相比,进行性核上性麻痹和多系统萎缩患者脑脊液中神经丝蛋白水平升高。
Mov Disord. 1998 Jan;13(1):70-7. doi: 10.1002/mds.870130116.
6
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)作为多系统萎缩(MSA)临床疾病严重程度和疾病进展的生物标志物。
J Neurol. 2024 Oct;271(10):6991-6999. doi: 10.1007/s00415-024-12647-z. Epub 2024 Sep 10.
7
Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.脑脊液和血浆中的神经丝轻链在多系统萎缩中的研究:一项前瞻性、纵向生物标志物研究。
Clin Auton Res. 2023 Dec;33(6):635-645. doi: 10.1007/s10286-023-00974-6. Epub 2023 Aug 21.
8
Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.脑脊液中α-突触核蛋白寡聚体和神经丝轻链可将多系统萎缩与路易体突触核蛋白病区分开来。
Ann Neurol. 2020 Sep;88(3):503-512. doi: 10.1002/ana.25824. Epub 2020 Aug 1.
9
Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.α-突触核蛋白寡聚体和神经丝轻链可预测单纯自主神经衰竭的表型转化。
Ann Neurol. 2021 Jun;89(6):1212-1220. doi: 10.1002/ana.26089. Epub 2021 Apr 30.
10
Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy.多系统萎缩患者脑脊液生物标志物(包括神经元-神经胶质 2 和神经丝轻链)的临床相关性。
Parkinsonism Relat Disord. 2022 Sep;102:30-35. doi: 10.1016/j.parkreldis.2022.07.007. Epub 2022 Jul 30.

引用本文的文献

1
Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis.帕金森病和非典型帕金森综合征中的脑脊液和血液神经丝轻链:系统评价和贝叶斯网络荟萃分析
J Neurol. 2025 Apr 3;272(4):311. doi: 10.1007/s00415-025-13051-x.
2
Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis.多系统萎缩患者脑脊液和血液中的神经丝轻链:一项系统评价和荟萃分析
Brain Sci. 2025 Feb 25;15(3):241. doi: 10.3390/brainsci15030241.
3
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).

本文引用的文献

1
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.血液和脑脊液中的神经丝轻链作为小鼠模型和神经退行性疾病中疾病进展的标志物。
Neuron. 2016 Jul 6;91(1):56-66. doi: 10.1016/j.neuron.2016.05.018. Epub 2016 Jun 9.
2
Mechanisms and prevention of sudden death in multiple system atrophy.多系统萎缩猝死的机制与预防
Parkinsonism Relat Disord. 2016 Sep;30:1-6. doi: 10.1016/j.parkreldis.2016.04.011. Epub 2016 Apr 14.
3
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)作为多系统萎缩(MSA)临床疾病严重程度和疾病进展的生物标志物。
J Neurol. 2024 Oct;271(10):6991-6999. doi: 10.1007/s00415-024-12647-z. Epub 2024 Sep 10.
4
Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke.循环神经丝轻链水平作为缺血性脑卒中后梗死和脑白质高信号体积的生物标志物。
Sci Rep. 2024 Jul 13;14(1):16180. doi: 10.1038/s41598-024-67232-1.
5
Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study.血浆神经丝轻链在多系统萎缩中的诊断和预后性能:一项横断面和纵向研究。
J Neurol. 2023 Sep;270(9):4248-4261. doi: 10.1007/s00415-023-11741-y. Epub 2023 May 15.
6
The 2022 Lady Estelle Wolfson lectureship on neurofilaments.2022 年埃斯特尔·沃尔夫森夫人神经丝讲座。
J Neurochem. 2022 Nov;163(3):179-219. doi: 10.1111/jnc.15682. Epub 2022 Sep 19.
7
Update on CSF Biomarkers in Parkinson's Disease.帕金森病脑脊液生物标志物研究进展。
Biomolecules. 2022 Feb 18;12(2):329. doi: 10.3390/biom12020329.
8
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium.路易体痴呆的体液和组织生物标志物:LBDA研讨会报告。
Front Neurol. 2022 Jan 31;12:805135. doi: 10.3389/fneur.2021.805135. eCollection 2021.
9
Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson's Disease: A Meta-Analysis.多系统萎缩症与帕金森病的脑脊液生物标志物:荟萃分析。
Behav Neurol. 2021 May 31;2021:5559383. doi: 10.1155/2021/5559383. eCollection 2021.
10
Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms: A protocol for systematic review and meta-analysis.帕金森病和非典型帕金森综合征中的血液神经丝轻链:系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Oct 2;99(40):e21871. doi: 10.1097/MD.0000000000021871.
与早期帕金森病疾病异质性相关的脑脊液生物标志物:帕金森病进展标志物计划研究
Acta Neuropathol. 2016 Jun;131(6):935-49. doi: 10.1007/s00401-016-1552-2. Epub 2016 Mar 28.
4
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.CSF 神经丝轻链反映 ALS 皮质脊髓束退变。
Ann Clin Transl Neurol. 2015 Jul;2(7):748-55. doi: 10.1002/acn3.212. Epub 2015 May 25.
5
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.脑脊髓液模式与早期帕金森病患者未来痴呆风险的关系。
JAMA Neurol. 2015 Oct;72(10):1175-82. doi: 10.1001/jamaneurol.2015.1449.
6
CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.脑脊液神经丝轻链而非FLT3配体可区分帕金森氏症相关疾病。
Front Neurol. 2015 May 5;6:91. doi: 10.3389/fneur.2015.00091. eCollection 2015.
7
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.多系统萎缩中的体液生物标志物:MSA生物标志物倡议综述
Neurobiol Dis. 2015 Aug;80:29-41. doi: 10.1016/j.nbd.2015.05.004. Epub 2015 May 15.
8
Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.脑脊液中神经丝轻链水平可区分帕金森病与非典型帕金森综合征:一项荟萃分析的证据
J Neurol Sci. 2015 May 15;352(1-2):84-7. doi: 10.1016/j.jns.2015.03.041. Epub 2015 Apr 7.
9
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.一个由九种脑脊液生物标志物组成的小组可能可以识别出具有非典型帕金森综合征的患者。
J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1240-7. doi: 10.1136/jnnp-2014-309562. Epub 2015 Jan 14.
10
Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker.向大脑注射α-突触核蛋白会诱发多种蛋白质病、胶质细胞增生以及一种神经元损伤标志物。
J Neurosci. 2014 Sep 10;34(37):12368-78. doi: 10.1523/JNEUROSCI.2102-14.2014.